IXC 5.56% 7.6¢ invex therapeutics ltd

Ann: Appendix 4D and Half-year Report, page-5

  1. 335 Posts.
    lightbulb Created with Sketch. 147
    Presendin
    - Love the name. Homage to the peptide basis of it, but clear differentiation for health providers to Exenatide for Diabetes.
    - Are Trade Mark applications publicly available? I tried searching, but I couldn't find it - Trade Mark Application No UK00003462892. Any know how to.

    Vesting Conditons and Options
    - I agree with GiveUsAChance - Complete speculation, but I anticipate that this is may be an Institutional Investor.
    - They may be providing a service on a quid-pro-quo basis e.g. roadshows in order to appreciate the share price hence the options vesting if the price reaches $X or is above $X for YY days.
    - I expect it will be useful for the company to have a higher price when they need to raise more capital from the market to fund additional indications e.g. TBI, Stroke.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.6¢
Change
0.004(5.56%)
Mkt cap ! $5.711M
Open High Low Value Volume
7.5¢ 7.6¢ 7.5¢ $167 2.216K

Buyers (Bids)

No. Vol. Price($)
1 40000 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 4000 1
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.